Skip to main content Accessibility help
×
Home
Hostname: page-component-77ffc5d9c7-5dsxc Total loading time: 0.575 Render date: 2021-04-22T15:25:09.502Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": false, "newCiteModal": false, "newCitedByModal": true }

Depot antipsychotic prophylaxis in bipolar affective disorder

Published online by Cambridge University Press:  13 June 2014

R O'Toole
Affiliation:
Department of Psychiatry, University College Hospital, Galway, Ireland

Abstract

Objective: Depot antipsychotic medication is often prescribed as maintenance treatment for patients with bipolar affective disorder. In this study we examined the case notes of 14 patients with bipolar disorder who had been prescribed depot antipsychotics. Our aim was to establish the effectiveness of depot medication in this group.

Method: We calculated the total number of hospital admissions, length of hospital stay, and total number of affective episodes for each patient from the onset of their illness to the time of the study. The frequency of affective episodes and hospital admission were compared during periods on or off depot medication.

Results: Treatment with depot antipsychotics was associated with a significant decrease in the number of hospital admissions, overall affective episodes and manic episodes in particular.

Conclusions: Prophylactic treatment with depot antipsychotics may be useful for certain patients with bipolar disorder, in particular those patients who experience frequent manic episodes. Further proof of the efficacy of depot antipsychotics in the prophylaxis of bipolar affective disorder requires the completion of a double-blind prospective trial.

Type
Brief Reports
Copyright
Copyright © Cambridge University Press 1999

Access options

Get access to the full version of this content by using one of the access options below.

References

1.Prien, R, Potter, W. NIMH workshop report on treatment of bipolar disorder. Psychopharmacol Bull 1990; 26: 409–27.Google ScholarPubMed
2.Maarbjerg, K, Aagard, J, Vestergaard, P. Adherence to lithium prophylaxis: Clinical predictors and patient's reasons for non-adherence. Pharmacopsychiat 1988; 21: 121–5.CrossRefGoogle Scholar
3.Peselow, E, Fieve, R, DiFiglia, C, Sanfilipo, M. Lithium prophylaxis of bipolar illness. The value of combination treatment. Br J Psychiat 1994; 164: 208–15.CrossRefGoogle ScholarPubMed
4.Verdoux, H, Gonzales, B, Takei, N, Bourgeois, M. A survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients. J Affect Disord 1996; 38: 81–7.CrossRefGoogle ScholarPubMed
5.American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiat 1994; 12: 136.Google Scholar
6.Naylor, J, Scott, C. Depot injections for affective disorders. Br J Psychiat 1980; 5: 108.Google Scholar
7.Lowe, M, Batchelor, D. Depot neuroleptics and manic depressive psychosis. Int J Clin Psychopharmacol 1986; suppl: 5362.Google Scholar
8.White, E, Cheung, P, Silverstone, T. Depot antipsychotics in bipolar affective disorder. Internat Clin Psychopharmacol 1993; 8: 119–22.CrossRefGoogle ScholarPubMed
9.Littlejohn, R, Leslie, F, Cookson, J. Depot antipsychotics in the prophylaxis of bipolar affective disorder. Br J Psychiat 1994; 165: 827–9.CrossRefGoogle ScholarPubMed
10.Esparon, J, Kolloori, J, Naylor, G, Mc, Harg A, Amith, AH, Hopwood, S. Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic depressive patients. Br J Psychiat 1986; 148: 723–5.CrossRefGoogle ScholarPubMed
11.Ahlfors, U, Baastrup, P, Dencker, Set al.Flupenthixol decanoate in recurrent manic depressive illness: A comparison with lithium. Acta Psychiat Scand 1981; 226–37.CrossRefGoogle ScholarPubMed

Full text views

Full text views reflects PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.

Total number of HTML views: 0
Total number of PDF views: 12 *
View data table for this chart

* Views captured on Cambridge Core between September 2016 - 22nd April 2021. This data will be updated every 24 hours.

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Depot antipsychotic prophylaxis in bipolar affective disorder
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Depot antipsychotic prophylaxis in bipolar affective disorder
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Depot antipsychotic prophylaxis in bipolar affective disorder
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *